Vivo Ventures V, LLC
CIK 0001399028 Name as filed on the most recent filing
Filed as Vivo Ventures V, LLC (20)
61 transaction lines · from 20 filings · filed 2013-05-20 to 2019-12-03 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Soleno Therapeutics Inc 11 filings
- ISSUER Sagent Pharmaceuticals, Inc. 3 filings
- ISSUER MEI Pharma, Inc. 6 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
3 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2019-12-02 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 34,028 disposed | 1.62 | 55,125.36 | Form 4, filing 0001213900-19-025237 | |
| 2019-11-27 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 2,898 disposed | 1.53 | 4,433.94 | Form 4, filing 0001213900-19-024996 | |
| 2019-11-26 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 15,171 disposed | 1.55 | 23,515.05 | Form 4, filing 0001213900-19-024996 | |
| 2019-11-25 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 14,775 disposed | 1.56 | 23,049.00 | Form 4, filing 0001213900-19-024649 | |
| 2019-11-22 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 2,600 disposed | 1.55 | 4,030.00 | Form 4, filing 0001213900-19-024649 | |
| 2019-11-21 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 44,296 disposed | 1.55 | 68,658.80 | Form 4, filing 0001213900-19-024649 | |
| 2019-11-20 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 40,929 disposed | 1.55 | 63,439.95 | Form 4, filing 0001213900-19-024233 | |
| 2019-11-19 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 600 disposed | 1.55 | 930.00 | Form 4, filing 0001213900-19-024233 | |
| 2019-11-18 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 100 disposed | 1.55 | 155.00 | Form 4, filing 0001213900-19-024233 | |
| 2019-11-15 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 51,404 disposed | 1.55 | 79,676.20 | Form 4, filing 0001213900-19-023778 | |
| 2019-11-14 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 31,391 disposed | 1.55 | 48,656.05 | Form 4, filing 0001213900-19-023778 | |
| 2019-11-13 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 14,229 disposed | 1.55 | 22,054.95 | Form 4, filing 0001213900-19-023778 | |
| 2019-11-05 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 8,764 disposed | 1.55 | 13,584.20 | Form 4, filing 0001213900-19-022412 | |
| 2019-11-04 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 214,682 disposed | 1.58 | 339,197.56 | Form 4, filing 0001213900-19-021959 | |
| 2019-11-01 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 94,911 disposed | 1.55 | 147,112.05 | Form 4, filing 0001213900-19-021959 | |
| 2019-10-31 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 24,824 disposed | 1.55 | 38,477.20 | Form 4, filing 0001213900-19-021959 | |
| 2019-10-28 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 7,225 disposed | 1.55 | 11,198.75 | Form 4, filing 0001213900-19-021314 | |
| 2019-10-24 |
Soleno Therapeutics Inc SLNO |
S, Open-market sale | 23,322 disposed | 1.60 | 37,315.20 | Form 4, filing 0001213900-19-021314 | |
| 2017-12-15 |
Soleno Therapeutics Inc SLNO |
P, Open-market purchase | 1,072,888 acquired | 1.84 | 1,976,796.14 | Form 4, filing 0000899243-17-029263 | |
| 2017-12-15 |
Soleno Therapeutics Inc SLNO |
P, Open-market purchase | 12,592 acquired | 1.84 | 23,200.76 | Form 4, filing 0000899243-17-029263 | |
| 2017-03-07 |
Capnia, Inc. CAPN |
P, Open-market purchase | 1,394,158 acquired | 0.96 | 1,338,391.68 | Form 4, filing 0000899243-17-007102 | |
| 2017-03-07 |
Capnia, Inc. CAPN |
P, Open-market purchase | 76,850 acquired | Not reported | Not priced | Form 4, filing 0000899243-17-007102 | |
| 2017-03-07 |
Capnia, Inc. CAPN |
P, Open-market purchase | 16,303 acquired | 0.96 | 15,650.88 | Form 4, filing 0000899243-17-007102 | |
| 2017-03-07 |
Capnia, Inc. CAPN |
P, Open-market purchase | 902 acquired | Not reported | Not priced | Form 4, filing 0000899243-17-007102 | |
| 2016-04-21 |
Sagent Pharmaceuticals, Inc. SGNT |
S, Open-market sale | 1,982 disposed | 13.55 | 26,856.10 | Form 4, filing 0000904454-16-001183 | |
| 2016-04-21 |
Sagent Pharmaceuticals, Inc. SGNT |
S, Open-market sale | 23 disposed | 13.55 | 311.65 | Form 4, filing 0000904454-16-001183 | |
| 2015-11-09 |
MEI Pharma, Inc. MEIP |
S, Open-market sale | 9,142 disposed | 1.75 | 15,998.50 | Form 4, filing 0001225208-15-020608 | |
| 2015-11-06 |
MEI Pharma, Inc. MEIP |
S, Open-market sale | 440 disposed | 1.85 | 814.00 | Form 4, filing 0001225208-15-020608 | |
| 2015-11-05 |
MEI Pharma, Inc. MEIP |
S, Open-market sale | 13,111 disposed | 1.91 | 25,042.01 | Form 4, filing 0001225208-15-020608 | |
| 2015-11-04 |
Sagent Pharmaceuticals, Inc. SGNT |
S, Open-market sale | 458,601 disposed | 15.45 | 7,085,385.45 | Form 4, filing 0000904454-15-000675 | |
| 2015-11-04 |
Sagent Pharmaceuticals, Inc. SGNT |
S, Open-market sale | 5,382 disposed | 15.45 | 83,151.90 | Form 4, filing 0000904454-15-000675 | |
| 2015-11-03 |
Sagent Pharmaceuticals, Inc. SGNT |
S, Open-market sale | 57,565 disposed | 16.32 | 939,460.80 | Form 4, filing 0000904454-15-000675 | |
| 2015-11-03 |
Sagent Pharmaceuticals, Inc. SGNT |
S, Open-market sale | 675 disposed | 16.32 | 11,016.00 | Form 4, filing 0000904454-15-000675 | |
| 2015-11-02 |
Sagent Pharmaceuticals, Inc. SGNT |
S, Open-market sale | 80,015 disposed | 16.87 | 1,349,813.04 | Form 4, filing 0000904454-15-000675 | |
| 2015-11-02 |
Sagent Pharmaceuticals, Inc. SGNT |
S, Open-market sale | 939 disposed | 16.87 | 15,840.46 | Form 4, filing 0000904454-15-000675 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
P, Open-market purchase | 1,936,843 acquired | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
P, Open-market purchase | 585,437 acquired | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
P, Open-market purchase | 348,800 acquired | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
P, Open-market purchase | 28,028 acquired | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
P, Open-market purchase | 22,729 acquired | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
P, Open-market purchase | 6,870 acquired | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
P, Open-market purchase | 6,689 acquired | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
P, Open-market purchase | 4,093 acquired | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
P, Open-market purchase | 122 acquired | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
S, Open-market sale | 1,567,878.63 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
S, Open-market sale | 18,400.64 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
S, Open-market sale | 9,427,594.51 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
S, Open-market sale | 136,440.76 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
S, Open-market sale | 110,642.23 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-070496 | |
| 2014-11-18 |
Capnia, Inc. CAPN |
S, Open-market sale | 32,569.17 disposed | Not reported | Not priced | Form 4, filing 0001209191-14-070496 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 3
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Vivo Ventures V, LLC, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001399028
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6